Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Gagne

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
The New England Journal of Medicine|July 7, 2021
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 VariantsVenkata-Viswanadh Edara, Benjamin A Pinsky, Mehul S Suthar, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Plos Pathogens|January 23, 2025
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2024
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
The New England Journal of Medicine|July 7, 2021
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 VariantsVenkata-Viswanadh Edara, Benjamin A Pinsky, Mehul S Suthar, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Nature Communications|August 12, 2024
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airwaysMatthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt, et al.
Plos Pathogens|January 23, 2025
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Biorxiv : the Preprint Server for Biology|April 29, 2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular VaccinesBreanna Kim, Rachel Roenicke, Peyton M Roeder, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2024
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaquesChristopher T Edwards, Kirti A Karunakaran, Elijah Garcia, et al.
Pageof 6